+91 8617752708

British Journal of Medicine and Medical Research, ISSN: 2231-0614,Vol.: 9, Issue.: 10


How Physician Age Affects Surveillance Intensity after Primary Ovarian Cancer Treatment


Akshar Y. Patel1*, Anit K. Behera1, Feng Gao2, David G. Mutch2, Katherine S. Virgo3, Randall K. Gibb2 and Frank E. Johnson1,4

1Department of Surgery, Saint Louis University Medical Center, St. Louis, MO, USA.

2Department of Biostatistics, Washington University, St. Louis, MO, USA.

3Health Services Research, American Cancer Society, Atlanta, GA, USA.

4Department of Surgery, Veterans Affairs Medical Center, St. Louis, MO, USA.

Article Information
(1) Edward J. Pavlik, Univ. Kentucky Medical Center, Division of Gynecological Oncology, USA.
(2) Chan Shen, Department of Biostatistics, MD Anderson Cancer Center, University of Texas, USA.
(1) Georgios Androutsopoulos, Department of Obstetrics and Gynecology, University of Patras, Greece.
(2) Anonymous, University of Kentucky, USA.
Complete Peer review History: http://sciencedomain.org/review-history/10225


Objective: We aimed to determine whether the variability in surveillance strategies after curative-intent primary treatment of ovarian cancer is related to practitioner age.

Materials and Methods: The 943 members of The Society of Gynecologic Oncology (SGO) were surveyed by conventional mail to quantify their surveillance strategies for patients with ovarian carcinoma after potentially curative initial treatment. We requested data regarding the recommended frequency of 10 commonly employed surveillance modalities. Age was used as a proxy for time since formal residency training.

Results: There were 283 responders: 58 were aged 30-39, 114 were aged 40-49, 70 were aged 50-59, and 41 were aged ≥ 60. Older gynecologic oncologists (60+) ordered office visits and pelvic examinations more frequently than younger gynecologic oncologists in year 1 (p<0.05). They ordered comprehensive metabolic panels more frequently during years 2-4 (p<0.05). They ordered CBCs more frequently during years 1-5 and year 10.

Conclusions: Although we had predicted that younger physicians would order surveillance tests more frequently than older physicians, we found the opposite. However, the differences attributable to age were clinically small. The results suggest that physician age does not account for a large portion of the known overall variation in the clinical practice of ovarian cancer patient surveillance after initial treatment. We propose that continuing medical education is a factor that can most plausibly explain this.

Keywords :

Age; surveillance; ovarian; carcinoma; outcomes.

Full Article - PDF    Page 1-7

DOI : 10.9734/BJMMR/2015/16127

Review History    Comments

Our Contacts

Guest House Road, Street no - 1/6,
Hooghly, West Bengal,

+91 8617752708


Third Floor, 207 Regent Street
London, W1B 3HH,

+44 20-3031-1429